Kerri M Clough-Gorr1, Aliza K Fink, Rebecca A Silliman. 1. Boston University Schools of Medicine, Boston University Medical Center, 88 East Newton Street, Robinson 2, Boston, MA 02118, USA. kmclough@bu.edu
Abstract
INTRODUCTION: Breast cancer is the most common type of cancer among older women. The vast majority of women with breast cancer become long-term survivors. METHODS: We selected a convenience sample of women with: (1) stage I-IIIa disease, (2) age 65-years or older, and (3) permission from physician to contact. Data were collected over 6-years of follow-up from consenting patients' medical records, telephone interviews, and the National Death Index. Before year 4 of follow-up we attempted to relocate women lost to follow-up using a single protocol and when successful, invited them to reenroll in the study. In this secondary data-analysis, baseline characteristics were compared among subjects with continuous follow-up, those who reenrolled, died, or were lost to follow-up. RESULTS: Among 660 subjects, 177 had complete follow-up, 182 reenrolled after a period of non-participation, 171 died, and 130 were lost to follow-up. No important differences were found between reenrolled women and those with continuous follow-up or those lost to follow-up. There were nominal differences in age and comorbidity among women lost to follow-up compared to those with complete follow-up. DISCUSSION/ CONCLUSIONS: This study highlights challenges in longitudinal research of cancer survivorship, specifically the potential benefit of reenrollment. IMPLICATIONS FOR CANCER SURVIVORS: Our findings provide a novel and promising approach to surmount some of the challenges in longitudinal research aimed at enhancing knowledge and the overall cancer survivorship experience of older adults.
INTRODUCTION:Breast cancer is the most common type of cancer among older women. The vast majority of women with breast cancer become long-term survivors. METHODS: We selected a convenience sample of women with: (1) stage I-IIIa disease, (2) age 65-years or older, and (3) permission from physician to contact. Data were collected over 6-years of follow-up from consenting patients' medical records, telephone interviews, and the National Death Index. Before year 4 of follow-up we attempted to relocate women lost to follow-up using a single protocol and when successful, invited them to reenroll in the study. In this secondary data-analysis, baseline characteristics were compared among subjects with continuous follow-up, those who reenrolled, died, or were lost to follow-up. RESULTS: Among 660 subjects, 177 had complete follow-up, 182 reenrolled after a period of non-participation, 171 died, and 130 were lost to follow-up. No important differences were found between reenrolled women and those with continuous follow-up or those lost to follow-up. There were nominal differences in age and comorbidity among women lost to follow-up compared to those with complete follow-up. DISCUSSION/ CONCLUSIONS: This study highlights challenges in longitudinal research of cancer survivorship, specifically the potential benefit of reenrollment. IMPLICATIONS FOR CANCER SURVIVORS: Our findings provide a novel and promising approach to surmount some of the challenges in longitudinal research aimed at enhancing knowledge and the overall cancer survivorship experience of older adults.
Authors: Allison J Applebaum; Wendy G Lichtenthal; Hayley A Pessin; Julia N Radomski; N Simay Gökbayrak; Aviva M Katz; Barry Rosenfeld; William Breitbart Journal: Psychooncology Date: 2011-07-12 Impact factor: 3.894
Authors: Hanne C Lie; Corina S Rueegg; Sophie D Fosså; Jon H Loge; Ellen Ruud; Cecilie E Kiserud Journal: J Cancer Surviv Date: 2019-04-16 Impact factor: 4.442
Authors: Baukje Miedema; Ryan Hamilton; Sue Tatemichi; Roanne Thomas-Maclean; Thomas F Hack; Elizabeth Quinlan; Anna Towers; Andrea Tilley; Winkle Kwan Journal: J Cancer Surviv Date: 2011-07-07 Impact factor: 4.442
Authors: Olivia Pagani; Karen N Price; Richard D Gelber; Monica Castiglione-Gertsch; Stig B Holmberg; Jurij Lindtner; Beat Thürlimann; John Collins; Martin F Fey; Alan S Coates; Aron Goldhirsch Journal: Breast Cancer Res Treat Date: 2009-01-10 Impact factor: 4.872
Authors: Nanette Mutrie; Anna Campbell; Sarah Barry; Kate Hefferon; Alex McConnachie; Diana Ritchie; Sian Tovey Journal: J Cancer Surviv Date: 2012-07-27 Impact factor: 4.442